MYRIAD GENETICS, INC.

MYGN ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2011

Total Assets: $610.8M

Liabilities Breakdown FY2011

Total Liabilities: $44.0M